These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9521303)

  • 1. Albendazole therapy for neurocysticercosis.
    Takayanagui OM
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521303
    [No Abstract]   [Full Text] [Related]  

  • 2. Albendazole therapy for neurocysticercosis.
    Ko DY; Chang GY
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
    Alla P; Carli P; Paris JF; Chagnon A
    Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurocysticercosis: optimal dose treatment with albendazole.
    Cruz I; Cruz ME; Carrasco F; Horton J
    J Neurol Sci; 1995 Nov; 133(1-2):152-4. PubMed ID: 8583218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
    Garg RK; Kar AM; Jain S
    J Assoc Physicians India; 1995 Oct; 43(10):706-7. PubMed ID: 8773009
    [No Abstract]   [Full Text] [Related]  

  • 6. Albendazole in neurocysticercosis.
    Padma MV; Behari M; Misra NK; Ahuja GK
    Natl Med J India; 1995; 8(6):255-8. PubMed ID: 8520442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral and subcutaneous cysticercosis treated with albendazole.
    Schmidt DK; Jordaan HF; Schneider JW; Cilliers J
    Int J Dermatol; 1995 Aug; 34(8):574-9. PubMed ID: 7591443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
    Garcia HH; Gilman RH; Horton J; Martinez M; Herrera G; Altamirano J; Cuba JM; Rios-Saavedra N; Verastegui M; Boero J; Gonzalez AE
    Neurology; 1997 May; 48(5):1421-7. PubMed ID: 9153484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe forms of neurocysticercosis: treatment with albendazole.
    Agapejev S; Da Silva MD; Ueda AK
    Arq Neuropsiquiatr; 1996 Mar; 54(1):82-93. PubMed ID: 8736150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short course of albendazole therapy for neurocysticercosis.
    Sotelo J; Penagos P; Escobedo F; Del Brutto OH
    Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albendazole therapy for neurocysticercosis.
    Del Brutto OH
    Arch Neurol; 1990 Dec; 47(12):1278-9. PubMed ID: 2252445
    [No Abstract]   [Full Text] [Related]  

  • 13. Albendazole--newer therapy for neurocysticercosis.
    Dharnidharka VR
    J R Soc Health; 1993 Feb; 113(1):51. PubMed ID: 8437170
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurocysticercosis: treatment with albendazole.
    Horton J
    Trans R Soc Trop Med Hyg; 1990; 84(1):174. PubMed ID: 2345923
    [No Abstract]   [Full Text] [Related]  

  • 15. Albendazole in neurocysticercosis.
    Kapil D; Vohra P
    Indian J Pediatr; 1993; 60(1):131-2. PubMed ID: 8244473
    [No Abstract]   [Full Text] [Related]  

  • 16. Albendazole therapy for neurocysticercosis.
    Escobedo F; Penagos P; Rodriguez J; Sotelo J
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Albendazole treatment in cerebral cysticercosis].
    Xiao ZX; Zhao CY; Liu YP
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):100-2, 127. PubMed ID: 3792122
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.
    Takayanagui OM; Lanchote VL; Marques MP; Bonato PS
    Ther Drug Monit; 1997 Feb; 19(1):51-5. PubMed ID: 9029747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of brain cysticercosis.
    Sotelo J
    Surg Neurol; 1997 Aug; 48(2):110-2. PubMed ID: 9242234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.